Response to Inhaled Nitric Oxide and Mortality Among Very Preterm Neonates With Pulmonary Hypertension
JAMA Network Open · 2025
DOI: 10.1001/jamanetworkopen.2024.58843 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift JAMA Network Open, 2025. Verfasst von Michelle Baczynski und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, Mount Sinai Hospital, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Nitric Oxide, Hypertension, Pulmonary, Infant, Premature, Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CIHR.
Abstract (Originalsprache)
Importance Clinical observations of immediate improvement in fraction of inspired oxygen (FiO 2 ) in a proportion of cases is often cited as the rationale for using inhaled nitric oxide (iNO) in the management of acute pulmonary hypertension among very preterm neonates (gestational age, <32 weeks). However, the clinical effectiveness of such a response pattern remains underinvestigated.
Objective
To identify factors associated with predischarge mortality among very preterm neonates receiving iNO for acute pulmonary hypertension, with specific a priori emphasis on iNO responsiveness. Design, Setting, and Participants This prospective observational cohort study was conducted from January 1, 2018, to December 31, 2022, at 12 Canadian tertiary neonatal intensive care units. Consecutive very preterm neonates who received iNO for a diagnosis of acute pulmonary hypertension and pretreatment FiO 2 of 0.50 or more were included. Neonates with congenital anomalies or those who were treated for chronic pulmonary hypertension with iNO were excluded. Early acute pulmonary hypertension (≤72 hours of age) and late acute pulmonary hypertension (>72 hours of age) cohorts were analyzed separately. Statistical analysis was performed from January 2023 to January 2024. Exposure Treatment with iNO for acute pulmonary hypertension. Main Outcomes and Measures The study cohorts were divided for comparison based on the primary outcome of predischarge mortality. Logistic regression analyses were used with predefined variables, including iNO responsiveness, to identify factors associated with mortality. A positive response to iNO was defined as a pre-iNO minus 4-hour post-iNO FiO 2 of 0.20 or more.
Results
The early acute pulmonary hypertension group (mean [SD] birth gestational age, 26.3 [2.4] weeks; median treatment age, 1 day [IQR, 1-2 days]; 147 boys [56%]) included 262 neonates; 179 (68%) had a pre-iNO FiO 2 of 1.0. The late acute pulmonary hypertension group (mean [SD] birth gestational age, 24.9 [1.7] weeks; median treatment age, 13 days [IQR, 9-20 days]; 72 boys [66%]) included 109 neonates; 51 (47%) had a pre-iNO FiO 2 of 1.0. Neonates with early acute pulmonary hypertension more frequently had a positive iNO response (71% [186 of 262] vs 41% [45 of 109]) and lower mortality (34% [90 of 262] vs 49% [53 of 109]) than those with late acute pulmonary hypertension. Accounting for pretreatment illness factors, greater reduction in FiO 2 with iNO remained associated with lower mortality for neonates with early acute pulmonary hypertension (adjusted odds ratio per FiO 2 reduction of 0.10, 0.74 [95% CI, 0.65-0.84]). For those with late acute pulmonary hypertension, however, only pretreatment illness severity (lower pre-iNO FiO 2 and higher pre-iNO pH), and not positive response to iNO (adjusted odds ratio, 0.47 [95% CI, 0.17-1.30]), was associated with mortality. Conclusions and Relevance In this cohort study of very preterm neonates with acute pulmonary hypertension treated with iNO, responsiveness to iNO was associated with improved outcomes during the first 72 hours of age. The prognostic role of iNO response in acute pulmonary hypertension presenting after 72 hours of age remains unclear. Future studies should investigate the distinct pathophysiological mechanisms associated with late acute pulmonary hypertension in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Paediatrics, Mount Sinai Hospital, Toronto, Ontario, Canada.
- Department of Newborn & Developmental Paediatrics, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
- Division of Neonatology, BC Children's & Women's Health Centre, Vancouver, British Columbia, Canada.
- Foothills Medical Centre, University of Calgary, Calgary, Alberta, Canada.
- Division of Neonatology, Royal Alexandra Hospital, Edmonton, Alberta, Canada.
- Division of Neonatology, London Health Sciences Centre, London, Ontario, Canada.
Förderung
- CIHR
Zitieren
APA
Baczynski, M., Weisz, D., Thomas, L., Fevrier, S., Castaldo, M., Soraisham, A., Hyderi, A., Agarushi, R., Bhattacharya, S., Lalitha, R., Sidhu, A., Abdul Wahab, M. G., Altit, G., Hébert, A., Louis, D., Elsayed, Y., Mitra, S., Deshpande, P., Kharrat, A., …, & Canadian Neonatal Network Investigators (2025). Response to Inhaled Nitric Oxide and Mortality Among Very Preterm Neonates With Pulmonary Hypertension. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2024.58843
Vancouver
Baczynski M, Weisz D, Thomas L, Fevrier S, Castaldo M, Soraisham A, et al. Response to Inhaled Nitric Oxide and Mortality Among Very Preterm Neonates With Pulmonary Hypertension. JAMA Network Open. 2025. doi:10.1001/jamanetworkopen.2024.58843
BibTeX
@article{Baczynski2025,
author = {Baczynski, Michelle and Weisz, Dany and Thomas, Laura and Fevrier, Stephanie and Castaldo, Michael and Soraisham, Amuchou and Hyderi, Abbas and Agarushi, Rula and Bhattacharya, Soume and Lalitha, Renjini and Sidhu, Amneet and Abdul Wahab, Muzafar Gani and Altit, Gabriel and Hébert, Audrey and Louis, Deepak and Elsayed, Yasser and Mitra, Souvik and Deshpande, Poorva and Kharrat, Ashraf and Zhu, Faith and Ting, Joseph and Yoon, Eugene and Shah, Prakesh S and Jain, Amish and Canadian Neonatal Network Investigators, Canadian Neonatal Network Investigators},
title = {Response to Inhaled Nitric Oxide and Mortality Among Very Preterm Neonates With Pulmonary Hypertension},
journal = {JAMA Network Open},
year = {2025},
doi = {10.1001/jamanetworkopen.2024.58843}
}
EUVIMED